TABLE 3.
Palliative opportunities and palliative care consultation stratified by diagnosis
| Lymphoid leukemia (N = 55) | Myeloid leukemia (N = 33) | Lymphoma (N = 4) | p‐value | |
|---|---|---|---|---|
| Palliative opportunity categories, median (IQR) a | ||||
| Disease‐related | 1.0 (3.0) | 1.0 (2.0) | 0.5 (2.0) | 0.84 |
| Treatment‐related | 0.0 (1.0) | 1.0 (1.0) | 0.0 (1.0) | 0.85 |
| Symptom‐related | 0.0 (1.0) | 0.0 (0.0) | 0.5 (1.0) | 0.02 |
| End‐of‐life‐related | 1.0 (0.0) | 1.0 (0.0) | 0.5 (1.0) | 0.27 |
| Intensive care‐related | 1.0 (2.0) | 1.0 (1.0) | 1.0 (0.5) | 0.48 |
| Total opportunities | 5.0 (5.0) | 4.0 (6.0) | 2.5 (4.5) | 0.46 |
| Palliative care consultation, n (%) | ||||
| Yes | 28 (50.9) | 16 (48.5) | 0 (0.0) | 0.14 |
| No | 27 (49.1) | 17 (51.5) | 4 (100.0) | |
| Reason for palliative care consultation, n (%) b | ||||
| Disease‐related | 18 (32.7) | 12 (36.4) | 0 (0.0) | 0.62 |
| Symptom management | 5 (9.1) | 2 (6.1) | 0 (0.0) | |
| End‐of‐life‐related | 5 (9.1) | 2 (6.1) | 0 (0.0) | |
Abbreviations: DNR, do not resuscitate; EOL, end of life; IQR, interquartile range.
a
Palliative opportunity categories as noted in Table 1.
b
Reason for palliative care consultation was similarly categorized as disease‐related (progression, relapse), symptom management (pain, dyspnea, fatigue, nausea/vomiting), and end‐of‐life (EOL) related (DNR, hospice enrollment, EOL management).